Skip to main content

Advertisement

Log in

Surgical treatment of hepatocellular carcinoma

  • Review Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Local tumor control is still the most important consideration in the treatment of hepatocellular carcinoma (HCC). Surgical treatments, including liver resection and liver transplantation are, and will remain, the first-line therapeutic strategies for local control in patients with primary HCC. Although aggressive liver resection is often performed for advanced HCC in patients with a large tumor, multiple tumors, or tumors with vascular invasion, liver transplantation is the preferred option, after taking into consideration age and tumor-related factors, when there is poor liver functional reserve. Preventing deterioration in liver function is the second priority in the treatment of HCC. When performing liver resection, extensive removal of noncancerous liver parenchyma during lobectomy or hemihepatectomy, should be avoided as much as possible. Anatomic resection, which refers to systematic elimination of the main tumor with its minute metastases, preserves liver function and is highly recommended. A treatment algorithm based on published evidence is now available, which helps us decide on the most suitable therapeutic option for individual patients, depending on the tumor characteristics and liver functional reserve.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Makuuchi M, Kosuge T, Takayama T, Yamazaki S, Kakazu T, Miyagawa S, et al. Surgery for small liver cancers. Semin Surg Oncol 1993;9:298–304.

    Article  PubMed  CAS  Google Scholar 

  2. The Liver Cancer Study Group of Japan. Primary liver cancer in Japan-the 17th report (in Japanese). 2002–2003.

  3. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, et al. Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res 2007;37:676–691.

    Article  PubMed  Google Scholar 

  4. Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 1999;229:322–330.

    Article  PubMed  CAS  Google Scholar 

  5. Imamura H, Seyama Y, Kokudo N, Maema A, Sugawara Y, Sano K, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003;138:1198–1206.

    Article  PubMed  Google Scholar 

  6. Makuuchi M, Hasegawa H, Yamazaki S. Intraoperative ultrasonic examination for hepatectomy. Jpn J Clin Oncol 1981;11:367–390.

    Google Scholar 

  7. Makuuchi M, Hasegawa H, Yamazaki S, Takayasu K. Four new hepatectomy procedures for resection of the right hepatic vein and preservation of the inferior right hepatic vein. Surg Gynecol Obstet 1987;164:68–72.

    PubMed  CAS  Google Scholar 

  8. Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1986;161:346–350.

    Google Scholar 

  9. Kokudo N, Bandai Y, Imanishi H, Minagawa M, Uedera Y, Harihara Y, et al. Management of new hepatic nodules detected by intraoperative ultrasonography during hepatic resection for hepatocellular carcinoma. Surgery 1996;119:634–640.

    Article  PubMed  CAS  Google Scholar 

  10. Zhang K, Kokudo N, Hasegawa K, Arita J, Tang W, Aoki T, et al. Detection of new tumors by intraoperative ultrasonography during repeated hepatic resections for hepatocellular carcinoma. Arch Surg 2007;142:1170–1175.

    Article  PubMed  Google Scholar 

  11. Makuuchi M, Mori T, Gunven P, Yamazaki S, Hasegawa H. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet 1987;164:155–158.

    PubMed  CAS  Google Scholar 

  12. Pringle JH. Notes on the arrest of hepatic hemorrhage due to trauma. Ann Surg 1908;48:541–549.

    Article  PubMed  CAS  Google Scholar 

  13. Man K, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg 1997;226:704–711.

    Article  PubMed  CAS  Google Scholar 

  14. Heaney JP, Stanton WK, Halbert DS, Seidel J, Vice T. An improved technic for vascular isolation of the liver: experimental study and case reports. Ann Surg 1966;163:237–241.

    Article  PubMed  CAS  Google Scholar 

  15. Fortner JG, Shiu MH, Kinne DW, Kim DK, Castro EB, Watson RC, et al. Major hepatic resection using vascular isolation and hypothermic perfusion. Ann Surg 1974;180:644–652.

    Article  PubMed  CAS  Google Scholar 

  16. Huguet C, Nordlinger B, Bloch P, Conard J. Tolerance of the human liver to prolonged normothermic ischemia. A biological study of 20 patients submitted to extensive hepatectomy. Arch Surg 1978;113:1448–1451.

    PubMed  CAS  Google Scholar 

  17. Belghiti J, Noun R, Zante E, Ballet T, Sauvanet A. Portal triad clamping or hepatic vascular exclusion for major resection;a controlled study. Ann Surg 1996;224:155–161.

    Article  PubMed  CAS  Google Scholar 

  18. Clavien PA, Selzner M, Rüdiger HA, Graf R, Kadry Z, Rousson V, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003;238:843–850.

    Article  PubMed  Google Scholar 

  19. Imamura H, Takayama T, Sugawara Y, Kokudo N, Aoki T, Kaneko J, et al. Pringle’s manoeuvre in living donors. Lancet 2002;360(9350):2049–2050.

    Article  PubMed  Google Scholar 

  20. Kawasaki S, Makuuchi M, Matsunami H, Hashikura Y, Ikegami T, Chisuwa H, et al. Preoperative measurement of segmental liver volume of donors for living related liver transplantation. Hepatology 1993;18:1115–1120.

    Article  PubMed  CAS  Google Scholar 

  21. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunvén P, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery 1990;107:521–527.

    PubMed  CAS  Google Scholar 

  22. Azoulay D, Castaing D, Krissat J, Smail A, Hargreaves GM, Lemoine A, et al. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 2000;232:665–672.

    Article  PubMed  CAS  Google Scholar 

  23. Aoki T, Imamura H, Hasegawa K, Matsukura A, Sano K, Sugawara Y, et al. Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg 2004;139:766–774.

    Article  PubMed  Google Scholar 

  24. Imamura H, Matsuyama Y, Miyagawa Y, Ishida K, Shimada R, Miyagawa S, et al. Prognostic significance of anatomical resection and des-γ-carboxy prothrombin in patients with hepatocellular carcinoma. Br J Surg 1999;86:1032–1038.

    Article  PubMed  CAS  Google Scholar 

  25. Grazi GL, Ercolani G, Pierangeli F, Del Gaudio M, Cescon M, Cavallari A, et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg 2001;234:71–78.

    Article  PubMed  CAS  Google Scholar 

  26. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg 2002;235:373–382.

    Article  PubMed  Google Scholar 

  27. Belghiti J. Panis Y. Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg 1991;214:114–117.

    Article  PubMed  CAS  Google Scholar 

  28. Kakazu T, Makuuchi M, Kawasaki S, Miyagawa S, Hashikura Y, Kosuge T, et al. Repeat hepatic resection for recurrent hepatocellular carcinoma. Hepato-Gastroenterology 1993;40:337–341.

    PubMed  CAS  Google Scholar 

  29. Nakajima Y, Ko S, Kanamura T, Nagao M, Kanehiro H, Hisanaga M, et al. Repeat liver resection for hepatocellular carcinoma. J Am Coll Surg 2001;192:339–344.

    Article  PubMed  CAS  Google Scholar 

  30. Regimbeau JM, Kianmanesh R, Farges O, Dondero F, Sauvanet A, Belghiti J. Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 2002;131:311–317.

    Article  PubMed  Google Scholar 

  31. Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, et al. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg 2005;242:252–259.

    Article  PubMed  Google Scholar 

  32. Wakai T, Shirai Y, Sakata J, Kaneko K, Cruz PV, Akazawa K, et al. Anatomic resection independently improves long-term survival in patients with T1–T2 hepatocellular carcinoma. Ann Surg Oncol 2007;14:1356–1365.

    Article  PubMed  Google Scholar 

  33. Eguchi S, Kanematsu T, Arii S, Okazaki M, Okita K, Omata M, et al.; Liver Cancer Study Group of Japan. Comparison of the outcomes between an anatomical subsegmentectomy and a nonanatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 2008;143:469–475.

    Article  PubMed  Google Scholar 

  34. Kubo S, Tanaka H, Takemura S, Yamamoto S, Hai S, Ichikawa T, et al. Surgical treatment for hepatocellular carcinoma detected after successful interferon therapy. Surg Today 2007;37:285–290.

    Article  PubMed  CAS  Google Scholar 

  35. Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus. Ann Surg 2001;233:379–384.

    Article  PubMed  CAS  Google Scholar 

  36. Inoue Y, Hasegawa K, Ishizawa T, Aoki T, Sano K, Beck Y, et al. Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma? Surgery 2009;145:9–19.

    Article  PubMed  Google Scholar 

  37. Furuta T, Sonoda T, Matsumata T, Kanematsu T, Sugimachi K. Hepatic resection for a hepatocellular carcinoma larger than 10 cm. J Surg Oncol 1992;51:114–117.

    Article  PubMed  CAS  Google Scholar 

  38. Liau KH, Ruo L, Shia J, Padela A, Gonen M, Jarnagin WR, et al. Outcome of partial hepatectomy for large (>10 cm) hepatocellular carcinoma. Cancer 2005;104:1948–1955.

    Article  PubMed  Google Scholar 

  39. Ng KK, Vauthey JN, Pawlik TM, Lauwers GY, Regimbeau JM, Belghiti J, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multiinstitutional database. Ann Surg Oncol 2005;12:364–733.

    Article  PubMed  Google Scholar 

  40. Chen XP, Qiu FZ, Wu ZD, Zhang ZW, Huang ZY, Chen YF. Long-term outcome of resection of large hepatocellular carcinoma. Br J Surg 2006;93:600–606.

    Article  PubMed  Google Scholar 

  41. Shah SA, Wei AC, Cleary SP, Yang I, McGilvray ID, Gallinger S, et al. Prognosis and results after resection of very large (>= 10 cm) hepatocellular carcinoma. J Gastrointest Surg 2007;11:589–595.

    Article  PubMed  Google Scholar 

  42. Poon RT, Fan ST, Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10cm in diameter. J Am Coll Surg 2002;194:592–602.

    Article  PubMed  Google Scholar 

  43. Pandey D, Lee KH, Wai CT, Wagholikar G, Tan KC. Long term outcome and prognostic factors for large hepatocellular carcinoma (10 cm or more) after surgical resection. Ann Surg Oncol 2007;14:2817–2823.

    Article  PubMed  Google Scholar 

  44. Momoi H, Shimahara Y, Terajima H, Iimuro Y, Yamamoto N, Yamamoto Y, et al. Management of adrenal metastasis from hepatocellular carcinoma. Surg Today 2002;32:1035–1041.

    Article  PubMed  Google Scholar 

  45. Nakamura T, Kimura T, Umehara Y, Suzuki K, Okamoto K, Okumura T, et al. Long-term survival after report resection of pulmonary metastases from hepatocellular carcinoma: report of two cases. Surg Today 2005;35:890–892.

    Article  PubMed  Google Scholar 

  46. Une Y, Misawa K, Shimamura T, Ogasawara K, Masuko Y, Sato N, et al. Treatment of lymph node recurrence in patients with hepatocellular carcinoma. Surg Today 1994;24:606–609.

    Article  PubMed  CAS  Google Scholar 

  47. Uenishi T, Hirohashi K, Shuto T, Kubo S, Tanaka H, Sakata C, et al. The clinical significance of lymph node metastases in patients undergoing surgery for hepatocellular carcinoma. Surg Today 2000;30:892–895.

    Article  PubMed  CAS  Google Scholar 

  48. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, et al. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 2000;356:802–807.

    Article  PubMed  CAS  Google Scholar 

  49. Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J, et al. Adjuvant intra-arterial lipiodol-iodine-131 for respectable hepatocellular carcinoma: a prospective randomized trial. Lancet 1999;353:797–801.

    Article  PubMed  CAS  Google Scholar 

  50. Hasegawa K, Takayama T, Ijichi M, Matsuyama Y, Imamura H, Sano K, et al. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. Hepatology 2006;44:891–895.

    Article  PubMed  CAS  Google Scholar 

  51. Abou-Alfa GK, Schwartz L, Ricci S, Amadori D, Santoro A, Figer A, et al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol 2006;24:4293–4300.

    Article  PubMed  CAS  Google Scholar 

  52. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008;359:378–390.

    Article  PubMed  CAS  Google Scholar 

  53. Kubo S, Nishiguchi S, Hirohashi K, Tanaka H, Shuto T, Yamazaki O, et al. Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial. Ann Intern Med 2001;134:963–967.

    PubMed  CAS  Google Scholar 

  54. Muto Y, Moriwaki H, Ninomiya M, Adachi S, Saito A, Takasaki KT, et al. Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. N Eng J Med 1996;334:1561–1567.

    Article  CAS  Google Scholar 

  55. Lo CM, Liu CL, Chan SC, Lam CM, Poon RT, Ng IO, et al. A randomized, controlled trial of postoperative adjuvant interferon therapy after resection of hepatocellular carcinoma. Ann Surg 2007;245:831–842.

    Article  PubMed  Google Scholar 

  56. Mazzaferro V, Romito R, Schiavo M, Mariani L, Camerini T, Bhoori S, et al. Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology 2006;44:1543–1554.

    Article  PubMed  CAS  Google Scholar 

  57. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Eng J Med 1996;334:693–699.

    Article  CAS  Google Scholar 

  58. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001;33:1394–1403.

    Article  PubMed  CAS  Google Scholar 

  59. Sugawara Y, Makuuchi M, Matsui Y, Kishi Y, Akamatsu N, Kaneko J, et al. Preemptive therapy for hepatitis C virus after living-donor liver transplantation. Transplantation 2004;78:1308–1311.

    Article  PubMed  CAS  Google Scholar 

  60. Santoyo J, Suarez MA, Fernández-Aguilar JL, Jiménez M, Perez Daga JA, Sánchez-Perez B, et al. Liver transplant results for hepatocellular carcinoma applying strict preoperative selection criteria. Transplant Proc 2005;37:1488–1490.

    Article  PubMed  CAS  Google Scholar 

  61. Benckert C, Jonas S, Thelen A, Spinelli A, Schumacher G, Heise M, et al. Liver transplantation for hepatocellular carcinoma in cirrhosis: prognostic parameters. Transplant Proc 2005;37:1693–1694.

    Article  PubMed  CAS  Google Scholar 

  62. Löhe F, Angele MK, Gerbes AL, Löhrs U, Jauch KW, Schauer RJ. Tumour size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma. Eur J Surg Oncol 2005;31:994–999.

    Article  PubMed  Google Scholar 

  63. Yao FY, Bass NM, Nikolai B, Merriman R, Davern TJ, Kerlan R, et al. A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: implication for the current organ allocation policy. Liver Transpl 2003;9:684–692.

    Article  PubMed  Google Scholar 

  64. Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, et al. The new liver allocation system: Moving toward evidence-based transplantation policy. Liver Transpl 2002;8:851–858.

    Article  PubMed  Google Scholar 

  65. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004;10:36–41.

    Article  PubMed  Google Scholar 

  66. Majno PE, Sarasin FP, Mentha G, Hadengue A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology 2000;31:899–906.

    Article  PubMed  CAS  Google Scholar 

  67. Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg 2003;238:508–518.

    Article  PubMed  Google Scholar 

  68. Takada Y, Ueda M, Ito T, Sakamoto S, Haga H, Maetani Y, et al. Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transpl 2006;12:912–919.

    Article  PubMed  Google Scholar 

  69. Belghiti J, Cortes A, Abdalla EK, Régimbeau JM, Prakash K, Durand F, et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 2003;238:885–892.

    Article  PubMed  Google Scholar 

  70. Hwang S, Lee SG, Moon DB, Ahn CS, Kim KH, Lee YJ, et al. Salvage living donor liver transplantation after prior liver resection for hepatocellular carcinoma. Liver Transpl 2007;13:741–746.

    Article  PubMed  Google Scholar 

  71. Hashikura Y, Makuuchi M, Kawasaki S, Matsunami H, Ikegami T, Nakazawa Y, et al. Successful living-related partial liver transplantation to an adult patient. Lancet 1994;343:1233–1234.

    Article  PubMed  CAS  Google Scholar 

  72. Lo CM. Complications and long-term outcome of living liver donors: a survey of 1,508 cases in five Asian centers. Transplantation 2003;75:S12–S15.

    Article  PubMed  Google Scholar 

  73. Yamaoka Y, Washida M, Honda K, Tanaka K, Mori K, Shimahara Y, et al. Liver transplantation using a right lobe graft from a living related donor. Transplantation 1994;57:1127–1130.

    Article  PubMed  CAS  Google Scholar 

  74. Lo CM, Fan ST, Liu CL, Wei WI, Lo RJ, Lai CL, et al. Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg 1997;226:261–269.

    Article  PubMed  CAS  Google Scholar 

  75. Todo S, Furukawa H. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 2004;240:451–461.

    Article  PubMed  Google Scholar 

  76. Umeshita K, Fujiwara K, Kiyosawa K, Makuuchi M, Satomi S, Sugimachi K, et al. Operative morbidity of living donors in Japan. Lancet 2003;362:687–690.

    Article  PubMed  Google Scholar 

  77. Belghiti J, Guevara OA, Noun R, Saldinger PF, Kianmanesh R. Liver hanging maneuver: a safe approach to right hepatectomy without liver mobilization. J Am Coll Surg 2001;193:109–111.

    Article  PubMed  CAS  Google Scholar 

  78. Suh KS, Lee HJ, Kim SH, Kim SB, Lee KU. Hanging maneuver in left hepatectomy. Hepato-Gastroenterology 2004;51:1464–1466.

    PubMed  Google Scholar 

  79. Kim SH, Park SJ, Lee SA, Lee WJ, Park JW, Kim CM. Isolated caudate lobectomy using the hanging maneuver. Surgery 2006;139:847–850.

    Article  PubMed  Google Scholar 

  80. Kokudo N, Imamura H, Sano K, Zhang K, Hasegawa K, Sugawara Y, et al. Ultrasonically assisted retrohepatic dissection for a liver hanging maneuver. Ann Surg 2005;242:651–654.

    Article  PubMed  Google Scholar 

  81. Gigot JF, Glineur D, Santiago Azagra J, Goergen M, Ceuterick M, Morino M, et al. Laparoscopic liver resection for malignant liver tumors: preliminary results of a multicenter European study. Ann Surg 2002;236:90–97.

    Article  PubMed  Google Scholar 

  82. Morino M, Morra I, Rosso E, Miglietta C, Garrone C. Laparoscopic vs open hepatic resection: a comparative study. Surg Endosc 2003;17:1914–1918.

    Article  PubMed  CAS  Google Scholar 

  83. Teramoto K, Kawamura T, Takamatsu S, Noguchi N, Nakamura N, Arii S. Laparoscopic and thoracoscopic partial hepatectomy for hepatocellular carcinoma. World J Surg 2003;27:1131–1136.

    Article  PubMed  Google Scholar 

  84. Koffron A, Geller D, Gamblin TC, Abecassis M. Laparoscopic liver surgery: shifting the management of liver tumors. Hepatology 2006;44:1694–1700.

    Article  PubMed  Google Scholar 

  85. Fan ST, Lai EC, Lo CM, Chu KM, Liu CL, Wong J. Hepatectomy with an ultrasonic dissector for hepatocellular carcinoma. Br J Surg 1996;83:117–120.

    Article  PubMed  CAS  Google Scholar 

  86. Takayama T, Makuuchi M, Kubota K, Harihara Y, Hui AM, Sano K, et al. Randomized comparison of ultrasonic vs clamp transaction of the liver. Arch Surg 2001;136:922–928.

    Article  PubMed  CAS  Google Scholar 

  87. Sakamoto Y, Yamamoto J, Kokudo N, Seki M, Kosuge T, Yamaguchi T, et al. Bloodless liver resection using the monopolar Floating Ball plus LigaSure diathermy: preliminary results of 16 liver resections. World J Surg 2004;28:166–172.

    Article  PubMed  Google Scholar 

  88. Arita J, Hasegawa K, Kokudo N, Sano K, Sugawara Y, Makuuchi M. Randomized clinical trial assessing effect of salinelinked radiofrequency coagulator on blood loss during hepatic resection. Br J Surg 2005;92:954–959.

    Article  PubMed  CAS  Google Scholar 

  89. Romano F, Franciosi C, Caprotti R, Uggeri F, Uggeri F. Hepatic surgery using the Ligasure vessel sealing system. World J Surg 2005;29:110–112.

    Article  PubMed  Google Scholar 

  90. Saiura A, Yamamoto J, Koga R, Sakamoto Y, Kokudo N, Seki M, et al. Usefulness of LigaSure for liver resection: analysis by randomized clinical trial. Am J Surg 2006;192:41–45.

    Article  PubMed  Google Scholar 

  91. Ikeda M, Hasegawa K, Aoki T, Ishizawa T, Sano K, Imamura H, et al. Vessel sealing system (LigaSure) on hepatic resection: a randomized controlled trial. Ann Surg; in press.

  92. Maema A, Imamura H, Takayama T, Sano K, Hui AM, Sugawara Y, et al. Impaired volume regeneration of split livers with partial venous disruption: a latent problem in partial liver transplantation. Transplantation 2002;73:765–769.

    Article  PubMed  Google Scholar 

  93. Sano K, Makuuchi M, Miki K, Maema A, Sugawara Y, Imamura H, et al. Evaluation of hepatic venous congestion: proposed indication criteria for hepatic vein reconstruction. Ann Surg 2002;236:241–247.

    Article  PubMed  Google Scholar 

  94. Sugawara Y, Makuuchi M, Sano K, Imamura H, Kaneko J, Ohkubo T, et al. Vein reconstruction in modified right liver graft for living donor liver transplantation. Ann Surg 2003;237:180–185.

    Article  PubMed  Google Scholar 

  95. Sugawara Y, Makuuchi M, Akamatsu N, Kishi Y, Niiya T, Kaneko J, et al. Refinement of venous reconstruction using cryopreserved veins in right liver grafts. Liver Transpl 2004;10:541–547.

    Article  PubMed  Google Scholar 

  96. Hashimoto T, Kokudo N, Aoki T, Natori T, Arita J, Sano K, et al. Reconstruction of middle hepatic vein using a rotating left hepatic vein flap. J Am Coll Surg 2004;199:656–660.

    Article  PubMed  Google Scholar 

  97. Aoki T, Sugawara Y, Imamura H, Seyama Y, Minagawa M, Hasegawa K, et al. Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer. J Am Coll Surg 2004;198:366–372.

    Article  PubMed  Google Scholar 

  98. Lamadé W, Glombitza G, Fischer L, Chiu P, Cárdenas CE Sr, Thorn M, et al. The impact of 3-dimensional reconstructions on operation planning in liver surgery. Arch Surg 2000;135:1256–1261.

    Article  PubMed  Google Scholar 

  99. Saito S, Yamanaka J, Miura K, Nakao N, Nagao T, Sugimoto T, et al. A novel 3D hepatectomy simulation based on liver circulation: application to liver resection and transplantation. Hepatology 2005;41:1297–1304.

    Article  PubMed  Google Scholar 

  100. Kamiyama T, Nakagawa T, Nakanishi K, Kamachi H, Onodera Y, Matsushita M, et al. Preoperative evaluation of hepatic vasculature by three-dimensional computed tomography in patients undergoing hepatectomy. World J Surg 2006;30:400–409.

    Article  PubMed  Google Scholar 

  101. Yamanaka J, Saito S, Iimuro Y, Hirano T, Okada T, Kuroda N, et al. The impact of 3-D virtual hepatectomy simulation in livingdonor liver transplantation. J Hepatobil Pancreat Surg 2006;13:363–369.

    Article  Google Scholar 

  102. Yamanaka J, Saito S, Fujimoto J. Impact of preoperative planning using virtual segmental volumetry on liver resection for hepatocellular carcinoma. World J Surg 2007;31:1249–1255.

    Article  PubMed  Google Scholar 

  103. Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology 2000;32:1224–1229.

    Article  PubMed  CAS  Google Scholar 

  104. Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122–130.

    Article  PubMed  Google Scholar 

  105. Huang GT, Lee PH, Tsang YM, Lai MY, Yang PM, Hu RH, et al. Percutaneous ethanol injection versus surgical resection for the treatment of small hepatocellular carcinoma: a prospective study. Ann Surg 2005;242:36–42.

    Article  PubMed  Google Scholar 

  106. Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for hepatocellular carcinoma. Ann Surg 2006;243:321–328.

    Article  PubMed  Google Scholar 

  107. Hasegawa K, Kokudo N, Makuuchi M. Surgery or ablation for hepatocellular carcinoma? Ann Surg 2008;247:557–558.

    Article  PubMed  Google Scholar 

  108. Group formed to establish “Guidelines for evidence-based clinical practice for the treatment of liver cancer”. Clinical practice guidelines for hepatocellular carcinoma (in Japanese). Tokyo: Kanehara; 2005.

    Google Scholar 

  109. Makuuchi M, Kokudo N. Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan. World J Gastroenterol 2006;12:828–829.

    PubMed  Google Scholar 

  110. Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329–338.

    Article  PubMed  CAS  Google Scholar 

  111. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005;42:1208–1236.

    Article  PubMed  Google Scholar 

  112. Ishizawa T, Hasegawa K, Aoki T, Takahashi M, Inoue Y, Sano K, et al. Neither multiple tumors nor portal hypertension are operative contraindications for hepatocellular carcinoma. Gastroenterology 2008;134:1908–1916.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hasegawa, K., Kokudo, N. Surgical treatment of hepatocellular carcinoma. Surg Today 39, 833–843 (2009). https://doi.org/10.1007/s00595-008-4024-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-008-4024-z

Key words

Navigation